Gene Page: CBX1
Summary ?
GeneID | 10951 |
Symbol | CBX1 |
Synonyms | CBX|HP1-BETA|HP1Hs-beta|HP1Hsbeta|M31|MOD1|p25beta |
Description | chromobox 1 |
Reference | MIM:604511|HGNC:HGNC:1551|Ensembl:ENSG00000108468|HPRD:05149|Vega:OTTHUMG00000150417 |
Gene type | protein-coding |
Map location | 17q21.32 |
Pascal p-value | 0.002 |
Sherlock p-value | 0.515 |
eGene | Myers' cis & trans |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs17073502 | chr4 | 183431488 | CBX1 | 10951 | 0.05 | trans | ||
rs16900783 | chr5 | 31245333 | CBX1 | 10951 | 0.15 | trans | ||
rs17141097 | chr7 | 19338527 | CBX1 | 10951 | 0.11 | trans | ||
rs7135241 | chr12 | 95163565 | CBX1 | 10951 | 0.03 | trans | ||
rs12591303 | chr15 | 56761869 | CBX1 | 10951 | 0.09 | trans | ||
snp_a-2279190 | 0 | CBX1 | 10951 | 0.03 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
No co-expressed genes in brain regions
Section IV. Protein-protein interaction annotation
Interactors | Aliases B | Official full name B | Experimental | Source | PubMed ID |
---|---|---|---|---|---|
ARL5A | ARFLP5 | ARL5 | ADP-ribosylation factor-like 5A | Two-hybrid | BioGRID | 12414990 |
C11orf30 | EMSY | FLJ90741 | GL002 | chromosome 11 open reading frame 30 | - | HPRD,BioGRID | 14651845 |
C1orf103 | FLJ11269 | RIF1 | RP11-96K19.1 | chromosome 1 open reading frame 103 | Two-hybrid | BioGRID | 16169070 |
CBX1 | CBX | HP1-BETA | HP1Hs-beta | HP1Hsbeta | M31 | MOD1 | p25beta | chromobox homolog 1 (HP1 beta homolog Drosophila ) | - | HPRD,BioGRID | 10747027 |11336697 |
CBX3 | HECH | HP1-GAMMA | HP1Hs-gamma | chromobox homolog 3 (HP1 gamma homolog, Drosophila) | - | HPRD,BioGRID | 11336697 |
CBX5 | HP1 | HP1A | chromobox homolog 5 (HP1 alpha homolog, Drosophila) | - | HPRD,BioGRID | 11336697 |
CHAF1A | CAF-1 | CAF1 | CAF1B | CAF1P150 | MGC71229 | P150 | chromatin assembly factor 1, subunit A (p150) | - | HPRD | 10549285 |
DNMT1 | AIM | CXXC9 | DNMT | FLJ16293 | MCMT | MGC104992 | DNA (cytosine-5-)-methyltransferase 1 | - | HPRD,BioGRID | 12711675 |
DNMT3A | DNMT3A2 | M.HsaIIIA | DNA (cytosine-5-)-methyltransferase 3 alpha | - | HPRD,BioGRID | 12711675 |
DNMT3B | ICF | M.HsaIIIB | DNA (cytosine-5-)-methyltransferase 3 beta | DNMT3B interacts with HP1-beta. This interaction was modeled on a demonstrated interaction between mouse Dnmt3b1 and human HP1-beta. | BIND | 15120635 |
DNMT3B | ICF | M.HsaIIIB | DNA (cytosine-5-)-methyltransferase 3 beta | - | HPRD,BioGRID | 12867029 |
HIST1H3C | H3.1 | H3/c | H3FC | histone cluster 1, H3c | - | HPRD | 11882902 |
MKI67 | KIA | Ki-67 | antigen identified by monoclonal antibody Ki-67 | pKi-67 interacts with the CS domain of HP1 protein via its C-terminus. This interaction was modeled on a demonstrated interaction between pKi-67 from human and HP1-beta from mouse. | BIND | 11793364 |
PIM1 | PIM | pim-1 oncogene | - | HPRD,BioGRID | 12111331 |
RB1 | OSRC | RB | p105-Rb | pRb | pp110 | retinoblastoma 1 | Reconstituted Complex | BioGRID | 12711675 |
RPL12 | - | ribosomal protein L12 | Two-hybrid | BioGRID | 16169070 |
SUV39H1 | KMT1A | MG44 | SUV39H | suppressor of variegation 3-9 homolog 1 (Drosophila) | - | HPRD,BioGRID | 10202156 |
TRIM24 | PTC6 | RNF82 | TF1A | TIF1 | TIF1A | TIF1ALPHA | hTIF1 | tripartite motif-containing 24 | - | HPRD,BioGRID | 10562550 |
TRIM28 | FLJ29029 | KAP1 | RNF96 | TF1B | TIF1B | tripartite motif-containing 28 | - | HPRD,BioGRID | 10562550 |11336697 |
UCHL1 | PARK5 | PGP9.5 | Uch-L1 | ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | Two-hybrid | BioGRID | 16169070 |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
IGARASHI ATF4 TARGETS DN | 90 | 65 | All SZGR 2.0 genes in this pathway |
DIAZ CHRONIC MEYLOGENOUS LEUKEMIA UP | 1382 | 904 | All SZGR 2.0 genes in this pathway |
AKL HTLV1 INFECTION UP | 27 | 16 | All SZGR 2.0 genes in this pathway |
DODD NASOPHARYNGEAL CARCINOMA DN | 1375 | 806 | All SZGR 2.0 genes in this pathway |
ENK UV RESPONSE KERATINOCYTE DN | 485 | 334 | All SZGR 2.0 genes in this pathway |
BERENJENO TRANSFORMED BY RHOA REVERSIBLY DN | 29 | 21 | All SZGR 2.0 genes in this pathway |
GRAESSMANN APOPTOSIS BY DOXORUBICIN UP | 1142 | 669 | All SZGR 2.0 genes in this pathway |
GRAESSMANN APOPTOSIS BY DOXORUBICIN DN | 1781 | 1082 | All SZGR 2.0 genes in this pathway |
GRAESSMANN RESPONSE TO MC AND DOXORUBICIN UP | 612 | 367 | All SZGR 2.0 genes in this pathway |
GRAESSMANN RESPONSE TO MC AND DOXORUBICIN DN | 770 | 415 | All SZGR 2.0 genes in this pathway |
OUELLET OVARIAN CANCER INVASIVE VS LMP UP | 117 | 85 | All SZGR 2.0 genes in this pathway |
BERENJENO TRANSFORMED BY RHOA UP | 536 | 340 | All SZGR 2.0 genes in this pathway |
OUELLET CULTURED OVARIAN CANCER INVASIVE VS LMP UP | 69 | 40 | All SZGR 2.0 genes in this pathway |
SCHLOSSER SERUM RESPONSE DN | 712 | 443 | All SZGR 2.0 genes in this pathway |
PATIL LIVER CANCER | 747 | 453 | All SZGR 2.0 genes in this pathway |
PUJANA BRCA2 PCC NETWORK | 423 | 265 | All SZGR 2.0 genes in this pathway |
GOTZMANN EPITHELIAL TO MESENCHYMAL TRANSITION DN | 206 | 136 | All SZGR 2.0 genes in this pathway |
SHEN SMARCA2 TARGETS UP | 424 | 268 | All SZGR 2.0 genes in this pathway |
MORI LARGE PRE BII LYMPHOCYTE UP | 86 | 49 | All SZGR 2.0 genes in this pathway |
MORI IMMATURE B LYMPHOCYTE DN | 90 | 55 | All SZGR 2.0 genes in this pathway |
MORI EMU MYC LYMPHOMA BY ONSET TIME UP | 110 | 69 | All SZGR 2.0 genes in this pathway |
NIKOLSKY BREAST CANCER 17Q21 Q25 AMPLICON | 335 | 181 | All SZGR 2.0 genes in this pathway |
GOLUB ALL VS AML UP | 24 | 20 | All SZGR 2.0 genes in this pathway |
FLECHNER PBL KIDNEY TRANSPLANT REJECTED VS OK UP | 63 | 48 | All SZGR 2.0 genes in this pathway |
THEILGAARD NEUTROPHIL AT SKIN WOUND DN | 225 | 163 | All SZGR 2.0 genes in this pathway |
LY AGING PREMATURE DN | 30 | 17 | All SZGR 2.0 genes in this pathway |
IVANOVA HEMATOPOIESIS STEM CELL AND PROGENITOR | 681 | 420 | All SZGR 2.0 genes in this pathway |
XU GH1 AUTOCRINE TARGETS UP | 268 | 157 | All SZGR 2.0 genes in this pathway |
XU GH1 EXOGENOUS TARGETS DN | 120 | 69 | All SZGR 2.0 genes in this pathway |
MARSON BOUND BY E2F4 UNSTIMULATED | 728 | 415 | All SZGR 2.0 genes in this pathway |
FUJII YBX1 TARGETS DN | 202 | 132 | All SZGR 2.0 genes in this pathway |
BLUM RESPONSE TO SALIRASIB DN | 342 | 220 | All SZGR 2.0 genes in this pathway |
CHANG CORE SERUM RESPONSE UP | 212 | 128 | All SZGR 2.0 genes in this pathway |
AGUIRRE PANCREATIC CANCER COPY NUMBER UP | 298 | 174 | All SZGR 2.0 genes in this pathway |
HOFFMANN LARGE TO SMALL PRE BII LYMPHOCYTE UP | 163 | 102 | All SZGR 2.0 genes in this pathway |
BOYAULT LIVER CANCER SUBCLASS G123 UP | 45 | 21 | All SZGR 2.0 genes in this pathway |
YAGI AML WITH 11Q23 REARRANGED | 351 | 238 | All SZGR 2.0 genes in this pathway |
CAIRO HEPATOBLASTOMA UP | 207 | 143 | All SZGR 2.0 genes in this pathway |
DANG BOUND BY MYC | 1103 | 714 | All SZGR 2.0 genes in this pathway |
VERHAAK GLIOBLASTOMA PRONEURAL | 177 | 132 | All SZGR 2.0 genes in this pathway |
JOHNSTONE PARVB TARGETS 3 DN | 918 | 550 | All SZGR 2.0 genes in this pathway |
FEVR CTNNB1 TARGETS DN | 553 | 343 | All SZGR 2.0 genes in this pathway |
RAO BOUND BY SALL4 ISOFORM B | 517 | 302 | All SZGR 2.0 genes in this pathway |